Kaspofungin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
←Membuat halaman berisi '{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = | image = Caspofungin.svg | width = 275 | alt = <!-- Clinical data --> | pronounce = {{IPAc-en|ˌ|k|æ|s|p|oʊ|ˈ|f|ʌ|n|dʒ|ɪ|n}} {{respell|KAS|poh|FUN|jin}} | tradename = Cancidas | Drugs.com = {{drugs.com|monograph|caspofungin-acetate}} | MedlinePlus = a615001 | DailyMedID = Caspofungin | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category = | routes_of_admin...' Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
Baris 109:
Caspofungin adalah penghambat pertama sintesis (1→3)-β-D-glukan jamur yang disetujui oleh Badan Pengawas Obat dan Makanan Amerika Serikat.<ref name="Deresinski SC 2003 1445–1457">{{cite journal | vauthors = Deresinski SC, Stevens DA | title = Caspofungin | journal = Clinical Infectious Diseases | volume = 36 | issue = 11 | pages = 1445–57 | date = June 2003 | pmid = 12766841 | doi = 10.1086/375080 | doi-access = free }}</ref> Caspofungin diberikan secara intravena.<ref name="Cancidas FDA label" /> Obat ini tercantum dalam Daftar Obat Esensial Organisasi Kesehatan Dunia.<ref name="WHO23rd">{{cite book | vauthors = ((World Health Organization)) | title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) | year = 2023 | hdl = 10665/371090 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2023.02 | hdl-access=free }}</ref>
==Kegunaan dalam medis==
==Efek samping==
==Farmakologi==
== Referensi ==
{{reflist}}
[[Kategori:Antijamur]]
[[Category:Echinocandins]]
[[Kategori:Obat yang dikembangkan oleh Merck & Co.]]
[[Kategori:Obat Esensial Organisasi Kesehatan Dunia]]
| |||